Thu, Jul 10, 2014, 12:23 AM EDT - U.S. Markets open in 9 hrs 7 mins

Recent

% | $
Quotes you view appear here for quick access.

Conns Inc. Message Board

green_brite 11 posts  |  Last Activity: Jun 13, 2014 10:55 AM Member since: Jan 8, 2006
SortNewest  |  Oldest  |  Highest Rated Expand all messages
  • May 13, 2014 JENSEN JOSEPH
    Officer
    48,693 Direct Purchase at $4.11 per share. 200,128
    May 13, 2014 VAMVAKAS ELIAS
    Officer
    30,000 Direct Purchase at $3.99 per share. 119,700

    Sentiment: Strong Buy

  • Reply to

    highlights of the CC

    by green_brite May 9, 2014 11:50 AM
    green_brite green_brite May 9, 2014 11:53 AM Flag

    For more details, look at the CC transcript from Seeking Alpha.

    Sentiment: Strong Buy

  • green_brite by green_brite May 9, 2014 11:50 AM Flag

    1. As you all know our stock price has taken a pretty dramatic hit over the past few months. I have been out talking to investors for the past while and not surprisingly the first question I get is what’s wrong? Well I certainly I wish our stock price reflected this, I’m going to tell you that I feel our business is as good as it has ever been. In fact based on every customer discussion I have had and the all conferences and doctor meetings we have been to, I’m now more confident about our value proposition than ever.

    2. I don’t think you can ignore the weather and the majority of our business in the North East.

    3. This is a large Masters account. Several sites, many devices and equally important many doctors and they were joined TearLab in 2013 and if you look at the revenue that they provided throughout all of Q1 it's approximately $38,000.We have continued to work with this account throughout the end of last year and through this year so that improvement really didn’t start to drive until later in the first quarter and for the first month of the second quarter in April alone were $35,000 already.

    4. So this is not a 28 million year model and again we’re not moving off our guidance and we expect the payoff to be in the back half of the year.

    Sentiment: Strong Buy

  • green_brite by green_brite May 2, 2014 10:47 AM Flag

    From its website:
    Territory Manager - Sacramento 05/01/2014 1017
    Implementation Specialist 04/25/2014 1013
    Territory Manager - Los Angeles 04/25/2014 1001
    Operations Team Leader OcuHub 04/25/2014 1016
    Operations Team Representative OcuHub 04/25/2014 1015
    Operations Project Manager OcuHub 04/25/2014 1014
    Desktop Support Specialist Corporate 04/14/2014 1012
    Director of Human Resources Corporate 04/14/2014 1011
    Payroll & Reimbursement Administrator Corporate 04/10/2014 1010

    It has also attracted another executive recently to improve its execution. I think it'll beat the earnings estimate which has been revised very low.

    Sentiment: Strong Buy

  • Reply to

    analyst note - if anyone cares

    by micro00 Apr 28, 2014 7:54 AM
    green_brite green_brite Apr 28, 2014 9:40 AM Flag

    Thanks for the info!

    Sentiment: Strong Buy

  • green_brite by green_brite Apr 23, 2014 9:44 AM Flag

    I counted 90 offices (net) added in 14Q1, this compares to 66 for 13Q4. So I think Q1 revenue will be good and more likely to be a upside surprise.

    Sentiment: Strong Buy

  • green_brite by green_brite Apr 23, 2014 9:38 AM Flag

    I continue to see regular wins from tearlab's website, will add up to future recurring revenue stream.

    Health Partners Plans Now Covering Tear Osmolarity Test
    April 15, 2014 – Philadelphia, PA

    Health Partners Plans, a Philadelphia area Managed Care Organization, has announced that CPT 83861, tear osmolarity, has been added to the fee schedule for Optometrists and Ophthalmologists with coverage starting from 4/1/2014. Health Partners Plans offers Managed Medicaid, CHiP, and Medicare Advantage benefits for members within Philadelphia and its surrounding counties. If there are additional questions, please contact TearLab for additional information.

    QualCare Inc. Now Covers Tear Osmolarity Testing
    April 10, 2014 – New Jersey

    QualCare Inc., a New Jersey managed care plan is now covering CPT 83861, Tear Osmolarity within its Commercial and Medicare benefits. In order to receive payment, QualCare Inc. has advised all in-network providers to contact their Provider Relations Representative to update their contract to allow for in-office laboratory testing. If there are different contracts to cover multiple benefits, each contract would need updating. It is encouraged that when contacting Provider Relations to have all necessary CLIA information available. If there are additional questions, please contact TearLab for additional information.

    Sentiment: Strong Buy

  • Reply to

    Canaccord buy rec 3/13

    by gringo33339 Apr 15, 2014 6:08 PM
    green_brite green_brite Apr 21, 2014 11:14 AM Flag

    Next short interest data will come out on 4/25. Institutional ownership updates will come out on 5/15.

    Sentiment: Strong Buy

  • Reply to

    Canaccord buy rec 3/13

    by gringo33339 Apr 15, 2014 6:08 PM
    green_brite green_brite Apr 21, 2014 10:54 AM Flag

    Short sellers have been selling:
    3/31/2014 7,499,771 326,198 22.991468 6.76
    3/14/2014 6,263,635 353,290 17.729443 7.11

    That's 1236136 new shares shorted. I bet they shorted another 1 million shares since 3/31/2014 that drove down the price and cause margin calls for small investors. But with all the buyers scrambles to buy today, they will have to cover before 5/8 to avoid get caught in a short squeeze.

    Sentiment: Strong Buy

  • According to interactive brokers, TEAR is no longer shortable, and the borrowing cost has gone higher:
    16-APR-14 Yes -1.54% / 1.62% -1.54% / 1.62% -1.54% / 1.62%
    15-APR-14 Yes -1.54% / 1.62% -1.54% / 1.62% -1.54% / 1.62%
    14-APR-14 Yes -1.48% / 1.56% -1.54% / 1.50% -1.42% / 1.62%
    13-APR-14 Yes -1.42% / 1.50% -1.42% / 1.50% -1.42% / 1.50%
    12-APR-14 Yes -1.42% / 1.50% -1.42% / 1.50% -1.42% / 1.50%
    11-APR-14 Yes -1.42% / 1.50% -1.42% / 1.50% -1.42% / 1.50%
    10-APR-14 Yes -1.35% / 1.44% -1.42% / 1.38% -1.29% / 1.50%
    09-APR-14 Yes -1.29% / 1.38% -1.29% / 1.38% -1.29% / 1.38%
    08-APR-14 Yes -1.29% / 1.38% -1.29% / 1.38% -1.29% / 1.38%
    From 3/14 to 3/31, 1236136 more shares are shorted:
    3/31/2014 7,499,771 326,198 22.991468
    3/14/2014 6,263,635 353,290 17.729443
    Hang on there and wait for the trend to reverse.

    Sentiment: Strong Buy

  • Reply to

    Reimbursement Update

    by green_brite Apr 1, 2014 9:48 AM
    green_brite green_brite Apr 16, 2014 9:47 AM Flag

    QualCare Inc. Now Covers Tear Osmolarity Testing
    April 10, 2014 – New Jersey

    QualCare Inc., a New Jersey managed care plan is now covering CPT 83861, Tear Osmolarity within its Commercial and Medicare benefits. In order to receive payment, QualCare Inc. has advised all in-network providers to contact their Provider Relations Representative to update their contract to allow for in-office laboratory testing. If there are different contracts to cover multiple benefits, each contract would need updating. It is encouraged that when contacting Provider Relations to have all necessary CLIA information available. If there are additional questions, please contact TearLab for additional information.

    Sentiment: Strong Buy

CONN
47.66+0.33(+0.70%)Jul 9 4:00 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.